WEDNESDAY, SEPTEMBER 28, 2016

CDC advisory panel recommends HPV vaccine

CDC panel recommends Merck HPV vaccine | Courtesy of southerncytologysociety.com

The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC) added GARDASIL 9 to its list of recommended HPV vaccines, the nine-valent HPV vaccine's maker Merck said on Thursday.

The recommendations call for females between the ages of 9 and 26 and males between the ages of 9 and 21 receive the vaccine.

The CDC committee especially recommends the vaccine for people who have not yet received any HPV vaccine or finished the 3 doses.

Committee experts said GARDASIL 9 can be used to further or finish an HPV vaccination series for females and either GARDASIL or GARDASIL 9 can be used to further or finish the HPV vaccination series for males.

The U.S. Food and Drug Administration has not yet given approval of GARDASIL 9 specifically for people older than 16.

"The CDC has made increasing HPV vaccination rates a public health priority, and today's recommendation for GARDASIL 9 is an important milestone in the shared effort to help further reduce the burden of HPV-related cancers and diseases,” Merck Vaccines President Jacques Cholat said.

Organizations in this story

Merck 2000 Galloping Hill Rd Kenilworth, NJ 07033

Get notified the next time we write about Merck!